Related Experiment Videos
Syndrome X following renal transplantation
1University of California-Los Angeles, School of Medicine, Department of Medicine, Division of Nephrology and Endocrinology, 900 Veteran Avenue, Suite 24-130, Los Angeles, CA 90095, USA. sunicholas@mednet.ucla.edu
Current Hypertension Reports
|March 29, 2001
Summary
Postrenal transplantation patients often develop dysmetabolic syndrome, characterized by cardiovascular risks like high lipids and hypertension. Aggressively managing this syndrome can improve patient cardiovascular health and kidney transplant function.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Postrenal transplantation is associated with significant cardiovascular risk factors.
- These include atherogenic lipid profiles, hypertension, new-onset diabetes mellitus, and a prothrombotic state.
- These factors collectively define dysmetabolic syndrome (Syndrome X).
Purpose of the Study:
- To highlight the impact of dysmetabolic syndrome on cardiovascular disease and allograft dysfunction in postrenal transplant recipients.
- To emphasize the importance of recognizing and managing dysmetabolic syndrome in this patient population.
Main Methods:
- This abstract is based on a review of existing literature and clinical observations regarding postrenal transplant patients.
- No specific new experimental methods were detailed in the provided abstract.
Main Results:
- Dysmetabolic syndrome significantly increases the risk of cardiovascular disease and mortality in postrenal transplant patients.
- It also accelerates the progression of allograft dysfunction.
Conclusions:
- Recognition and aggressive management of dysmetabolic syndrome are crucial in postrenal allograft recipients.
- Effective management can favorably impact cardiovascular morbidity and mortality.
- It may also lead to prolonged allograft function.